We are live on ! Find out more
SCM

Superstring Capital Management Portfolio holdings

AUM $140M
1-Year Est. Return 323.19%
This Fund
S&P 500
This Quarter Est. Return
-20.91%
1 Year Est. Return
+323.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$79.3M
AUM Growth
-$71.9M
Cap. Flow
-$39.4M
Cap. Flow %
-49.61%
Top 10 Hldgs %
66.81%
Holding
58
New
21
Increased
4
Reduced
13
Closed
19

Top Buys

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$7.13M
2
TERN
Terns Pharmaceuticals
TERN
+$5.79M
3
ZLAB icon
Zai Lab
ZLAB
+$3.78M
4
ACLX
Arcellx
ACLX
+$3.21M
5
ARWR icon
Arrowhead Research
ARWR
+$2.73M

Top Sells

Rank Stock Value
1
IDYA icon
IDEAYA Biosciences
IDYA
+$9.53M
2
SVRA icon
Savara
SVRA
+$8.3M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$5.78M
4
ROIV icon
Roivant Sciences
ROIV
+$5.6M
5
CYTK icon
Cytokinetics
CYTK
+$5.51M

Sector Composition

Rank Sector Weight
1 Healthcare 99.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYRA
51
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-2,906
Closed -$904K
PRAX icon
52
Praxis Precision Medicines
PRAX
$8.59B
– –
-40,119
Closed -$2.45M
RNAM
53
DELISTED
Avidity Biosciences
RNAM
– –
-37,031
Closed -$945K
ROIV icon
54
Roivant Sciences
ROIV
$24.4B
– –
-531,019
Closed -$5.6M
SY
55
So-Young International
SY
$170M
– –
-182,742
Closed -$199K
URGN icon
56
UroGen Pharma
URGN
$1.95B
– –
-288,267
Closed -$4.32M
VRNA
57
DELISTED
Verona Pharma
VRNA
– –
-259,383
Closed -$4.17M
ALPN
58
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-9,038
Closed -$358K
1 2
3

Similar funds

GIM
Guild Investment Management Los Angeles, California $140M AUM 28.67% 1-Year Est. Return
SLWM
Stone Loft Wealth Management West Chester, Pennsylvania $140M AUM
NWA
Northwest Wealth Advisors Bellingham, Washington $140M AUM
WCM
WealthTrak Capital Management Virginia Beach, Virginia $140M AUM 17% 1-Year Est. Return
JD6
J Digital 6 Chicago, Illinois $140M AUM
CPC
CFC Planning Company Cicero, Indiana $140M AUM 22.33% 1-Year Est. Return
CFG
Chapman Financial Group Kailua, Hawaii $140M AUM 15.83% 1-Year Est. Return
RC
Rexford Capital Bellaire, Texas $140M AUM 28.19% 1-Year Est. Return

Superstring Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Superstring Capital Management held 58 positions worth $79.3M, down 48% from $151M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Superstring Capital Management withdrew a net $39.4M in Q2 2024, closing 19 positions and reducing 13 holdings. Its most notable exit was IDEAYA Biosciences, an estimated $9.53M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 97% a quarter earlier.

Against the trend, Superstring Capital Management opened a new position in Legend Biotech worth $6.85M.

  • Superstring Capital Management's largest Q2 2024 buy was Legend Biotech: 154,665 shares worth $6.85M.
  • Superstring Capital Management added most to Keros Therapeutics in Q2 2024, an estimated $2.17M increase.
  • Superstring Capital Management's biggest Q2 2024 reduction was Savara, cutting an estimated $8.3M.
  • Superstring Capital Management fully exited IDEAYA Biosciences in Q2 2024, selling an estimated $9.53M.
  • Superstring Capital Management's ten largest holdings make up 67% of its $79.3M portfolio in Q2 2024.
  • Superstring Capital Management opened 21 new positions and closed 19 in Q2 2024.
  • Superstring Capital Management's portfolio value fell 48% quarter-over-quarter to $79.3M.

Based on Superstring Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.